Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis

Fertility and Sterility

Volumn 89, Issue 5 SUPPL., 2008, Pages 1490-1496

  Galandrini, Ricciarda ^a,b   Porpora, Maria Grazia ^b   Stoppacciaro, Antonella ^a   Micucci, Federica ^a   Capuano, Cristina ^a   Tassi, Ilaria ^a   Di Felice, Alessia ^b   Benedetti Panici, Pierluigi ^b   Santoni, Angela ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD94 NKG2 receptors; endometriosis; HLA E; Peritoneal NK cells

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LAPAROSCOPY; LYSIS; NATURAL KILLER CELL; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; VENOUS BLOOD;

ADULT; ANTIGENS, CD94; ASCITIC FLUID; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENDOMETRIOSIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER;

EID: 43549126435     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.05.018     Document Type: Article

References (30)

1. Giudice L.C., and Kao L.C. Endometriosis. Lancet 364 (2004) 1789-1799
2. Ulukus M., and Arici A. Immunology of endometriosis. Minerva Ginecol 57 (2005) 237-248
3. Oosterlynck D.J., Meuleman C., Waer M., Vandeputte M., and Koninckx P.R. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 58 (1992) 290-295
4. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., and Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 62 (1994) 1086-1088
5. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
6. Moretta L., and Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 16 (2004) 626-633
7. Borrego F., Masilamani M., Kabat J., Sanni T.B., and Coligan J.E. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol 42 (2005) 485-488
8. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
9. Wu M.Y., Yang J.H., Chao K.H., Hwang J.L., Yang Y.S., and Ho H.N. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 74 (2000) 1187-1191
10. Maeda N., Izumiya C., Yamamoto Y., Oguri H., Kusume T., and Fukaya T. Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 77 (2002) 297-302
11. Galandrini R., Albi N., Tripodi G., Zarcone D., Terenzi A., Moretta A., et al. Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150 (1993) 4225-4235
12. Galandrini R., Micucci F., Tassi I., Cifone M.G., Cinque B., Piccoli M., et al. Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Blood 106 (2005) 577-583
13. Zhang C., Maeda N., Izumiya C., Yamamoto Y., Kusume T., Oguri H., et al. Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol 55 (2006) 106-114
14. Vernet-Tomas Mdel M., Perez-Ares C.T., Verdu N., Molinero J.L., Fernandez-Figueras M.T., and Carreras R. The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril 85 (2006) 78-83
15. Bianchini M., Levy E., Zucchini C., Pinski V., Macagno C., De Sanctis P., et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol 29 (2006) 83-94
16. Farag S.S., and Caligiuri M.A. Human natural killer cell development and biology. Blood Rev 20 (2006) 123-137
17. Mingari M.C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F., et al. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Proc Natl Acad Sci USA 95 (1998) 1172-1177
18. Sheu B.C., Chiou S.H., Lin H.H., Chow S.N., Huang S.C., Ho H.N., et al. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Cancer Res 65 (2005) 2921-2929
19. Arici A., Matalliotakis I., Goumenou A., Koumantakis G., Vassiliadis S., Selam B., et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Hum Reprod 18 (2003) 429-432
20. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95 (1998) 5199-5204
21. Ishitani A., Sageshima N., and Hatake K. The involvement of HLA-E and -F in pregnancy. J Reprod Immunol 69 (2006) 101-113
22. King A., Allan D.S., Bowen M., Powis S.J., Joseph S., Verma S., et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 30 (2000) 1623-1631
23. Kusumi M., Yamashita T., Fujii T., Nagamatsu T., Kozuma S., and Taketani Y. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. J Reprod Immunol 70 (2006) 33-42
24. Malmberg K.J., Levitsky V., Norell H., de Matos C.T., Carlsten M., Schedvins K., et al. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 110 (2002) 1515-1523
25. Jinushi M., Takehara T., Tatsumi T., Kanto T., Miyagi T., Suzuki T., et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 173 (2004) 6072-6081
26. Guma M., Angulo A., Vilches C., Gomez-Lozano N., Malats N., and Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104 (2004) 3664-3671
27. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., and Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 18 (1999) 4250-4260
28. Wu M.Y., and Ho H.N. The role of cytokines in endometriosis. Am J Reprod Immunol 49 (2003) 285-296
29. Carrington M., and Martin M.P. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 298 (2006) 225-257
30. Barlow D.H., and Kennedy S. Endometriosis: new genetic approaches and therapy. Annu Rev Med 56 (2005) 345-356